Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Jul 26, 2026
Rocket Lab (RKLB) Needs a +56% Rally to Reach $100 – What Stands in the Way

Rocket Lab (RKLB) Needs a +56% Rally to Reach $100 – What Stands in the Way

Key Takeaways

  • Rocket Lab shares closed at $63.91 on July 24, 2026, meaning the stock would need to climb approximately 56% to reclaim the psychologically significant $100 level.
  • The strongest bullish catalyst is Neutron, the company's medium-lift reusable rocket targeting a debut launch in the fourth quarter of 2026, which could unlock a $5.6 billion national security launch program and dramatically expand the revenue base.
  • Rocket Lab's record $2.2 billion backlog and 63.5% year-over-year revenue growth in Q1 2026 demonstrate strong operational momentum, while the pending $8 billion Iridium acquisition could transform the company into a vertically integrated space platform with recurring services revenue.
  • Valuation and dilution risks remain significant obstacles. The stock trades at roughly 66 times trailing sales, insider selling has weighed on sentiment, and a $3 billion at-the-market equity offering has raised concerns about shareholder dilution.
  • Wall Street consensus suggests $100 is achievable. The average analyst price target stands near $110, with most targets clustering between $96 and $135, though the Street-low target of $60 underscores the wide range of possible outcomes.

Why Investors Are Watching the $100 Level

After peaking near $151 in May 2026, Rocket Lab Corporation (NASDAQ: RKLB) has endured a punishing drawdown of more than 55%, wiping out the year's gains and sending shares tumbling into the mid-$60s. The speed and severity of the sell-off — driven by a broader post-SpaceX IPO rotation out of space stocks, a dilutive equity offering, and a securities class action — has left investors asking whether the stock can mount a meaningful recovery. The $100 round-number level has emerged as the most visible near-term milestone: it sits just below the analyst consensus, represents the threshold that separated the stock's rally phase from its correction, and carries the psychological weight that round numbers command in technical analysis.

Company Overview

Rocket Lab is an end-to-end space company headquartered in Long Beach, California, founded in 2006 by CEO Sir Peter Beck. Unlike pure-play launch providers, Rocket Lab operates across two segments: Launch Services, anchored by the frequently flown Electron small orbital rocket, and Space Systems, which designs and manufactures satellites, spacecraft components, and on-orbit infrastructure. The company has delivered more than 1,700 satellites to orbit, operates three launch pads across New Zealand and Virginia, and is developing Neutron, a medium-lift reusable rocket designed to compete directly with SpaceX's Falcon 9 in the constellation-deployment and national security markets. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

What Could Drive the Stock Back to $100

The single most important variable for the Rocket Lab thesis is Neutron's debut flight, now targeted for the fourth quarter of 2026. A successful first launch would make Rocket Lab eligible to compete for individual task orders under the Space Force's National Security Space Launch (NSSL) Phase 3 Lane 1 program, a contract vehicle carrying a $5.6 billion ceiling through 2029. The Archimedes engine that powers Neutron recently completed a full-duration qualification burn at NASA's Stennis Space Center — a milestone that keeps the timeline credible despite an earlier tank-test failure that pushed the schedule from mid-2026 into the fourth quarter.

Beyond Neutron, the fundamental momentum is difficult to dismiss. First-quarter fiscal 2026 revenue reached $200.35 million, up 63.5% year over year, while the contracted backlog swelled to a record $2.2 billion. Rocket Lab also secured an $816 million Space Development Agency contract for 18 tracking-layer satellites and was selected alongside Raytheon for the Golden Dome Space-Based Interceptor program — placing the company at the center of the highest-priority U.S. defense space budgets.

The pending $8 billion acquisition of Iridium Communications, announced in late June 2026, represents a transformative bet. If the deal closes as expected in mid-2027, Rocket Lab would add a global satellite communications network, L-band spectrum, and more than 2.5 million recurring subscribers — evolving from a launch provider into a vertically integrated space platform that more closely resembles the SpaceX model Morgan Stanley has cited in its analysis.

Analyst Consensus: Cautious Optimism

The broader analyst community remains constructive despite the sell-off. Across 22 analysts, the consensus rating is Moderate Buy, with an average price target of approximately $110, implying roughly 72% upside from the most recent close. High-profile targets include Needham at $120, Keybanc at $135, and Bank of America at $115. Morgan Stanley maintains an Overweight rating with a $105 base case while simultaneously raising its bull-case scenario to $293, reflecting the optionality tied to Neutron, Iridium, and Golden Dome contract conversions. On the more cautious side, Piper Sandler initiated coverage in mid-July with a Neutral rating and an $83 target, arguing the stock remains expensive even after falling more than 50% from its peak. The range of opinion — from $60 at Wells Fargo to $150 at the high end — underscores how much depends on execution over the next two quarters.

Risks That Could Prevent the Move

Rocket Lab remains an unprofitable company. Fiscal 2025 revenue of $601.8 million was accompanied by a net loss of $198 million, and the company trades at roughly 66 times trailing sales — a multiple that prices in years of flawless execution. Any Neutron delay beyond late 2026, whether from technical setbacks or certification hurdles, would delay the medium-lift revenue stream that the valuation thesis depends on and could trigger further equity dilution.

Additional headwinds include a $3 billion at-the-market equity offering announced in June, which raised dilution concerns, and insider selling from CEO Peter Beck, who disclosed the sale of nearly 3 million shares in early July. A securities class action filed over Neutron timeline disclosures has added legal uncertainty to the mix. Meanwhile, the post-SpaceX IPO rotation has not yet run its course, and with a beta of approximately 2.55, RKLB amplifies every shift in market sentiment — in both directions.

Technical Levels That Matter

From a technical perspective, $100 also aligns as the approximate midpoint between the 52-week high of $151 and key support near $60 — the Street-low analyst target and a level the stock tested during the recent sell-off. The 200-day simple moving average, sitting around $76, represents a nearer-term hurdle; the stock would need to reclaim that level before any sustained move toward triple digits gains credibility. The $80 to $85 zone, where the stock consolidated during portions of June and early July, may also act as an intermediate resistance area. I reviewed the recent patterns using Tickeron’s AI Pattern Search Engine to confirm the key levels.

Using AI Tools to Navigate Volatile Names

One tool I’ve found helpful for navigating stocks like this is Tickeron’s AI Daily Buy/Sell Signals. It uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical patterns, and AI-driven analysis. Rather than manually scanning charts and news feeds, I can use these signals to identify emerging opportunities, monitor existing positions, and spot shifts in market trends more efficiently. For investors tracking whether RKLB can sustain a recovery toward $100, automated signal monitoring can help filter the noise from the signal.

Final Assessment

Can Rocket Lab reach $100? The arithmetic says yes — a 56% rally from $63.91 is well within this stock's normal range of motion, and it has already traded well above $100 earlier in 2026. The question is less about capability and more about timing and conditions. A clean Neutron debut in the fourth quarter, continued backlog conversion at or above current growth rates, and tangible progress on the Iridium integration would likely provide the fundamental fuel to drive shares back through $100. Conversely, a Neutron delay into 2027, further dilution, or deteriorating sentiment across the space sector would make that target considerably more difficult. For now, $100 remains a reachable but non-trivial milestone — one that demands execution, not merely ambition. The upcoming Q2 earnings report on August 6 may offer the next meaningful signal about which direction the stock is poised to take.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: RKLB

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


RKLB sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for RKLB moved below the 200-day moving average on August 27, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RKLB as a result. In 70 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

The Moving Average Convergence Divergence Histogram (MACD) for RKLB turned negative on August 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 36 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RKLB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

The Aroon Indicator for RKLB entered a downward trend on September 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RKLB's RSI Oscillator exited the oversold zone, 29 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +3.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where RKLB advanced for three days, in 260 of 297 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

RKLB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 61 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.455) is normal, around the industry mean (6.216). P/E Ratio (0.000) is within average values for comparable stocks, (55.286). RKLB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.883). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (47.619) is also within normal values, averaging (18.486).

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. RKLB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.75B. The market cap for tickers in the group ranges from 4.49 to 1.95T. SPCX holds the highest valuation in this group at 1.95T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -3%. For the same Industry, the average monthly price growth was -18%, and the average quarterly price growth was -9%. ELMT experienced the highest price growth at 28%, while FJET experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 12%. For the same stocks of the Industry, the average monthly volume growth was -32% and the average quarterly volume growth was -17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 70
Price Growth Rating: 66
SMR Rating: 77
Profit Risk Rating: 74
Seasonality Score: 2 (-100 ... +100)
View a ticker or compare two or three
RKLB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Profile
Details
Industry
N/A
Address
3881 McGowen Street
Phone
+1 714 465-5737
Employees
2600
Web
https://www.rocketlabusa.com
Interact to see
Advertisement
FICO fell over 9% today, extending a multi‑week downtrend that has already knocked the stock more than 7% lower since its last earnings update. The decline comes despite strong recent financial results, including double‑digit revenue growth, expanding margins, and repeated earnings beats.
RERE fell roughly 10% today, giving back a portion of its strong gains over the past year and month, as traders reacted to fresh earnings and guidance. The company delivered robust Q4 2025 results, with revenue growth near 30% year over year and earnings per share ahead of consensus estimates, underscoring continued operational momentum.
Top hedge funds like Millennium, Citadel, and Bridgewater showed limited direct accumulation of penny stocks in Q4 2025 13F filings, but rotations into biotech, energy, and defense sectors highlight indirect interest in low-priced plays under $5. New entries and increased positions focused on volatile sectors like biotech (e.g., ABCL) and energy (e.g., AMPY), with full exits from overvalued names signaling a hunt for undervalued pennies amid market uncertainty.
Penny stocks in the oil sector are exploding in trading volume amid a massive oil price rally, with the USO ETF hitting a record $12.4 billion in daily trades—up 1,000% YTD and surpassing peaks from 2020, 2022, and 2025. Geopolitical tensions from the ongoing Iran war are driving oil above $100 per barrel, creating supply shocks and opportunities for high-volatility plays in exploration, drilling, and production.
NTSK shares are trading down approximately 20% in premarket trading on March 12, 2026, following the company's Q4 fiscal 2026 earnings release after the close on March 11. The primary catalyst is not the earnings themselves — which beat expectations — but an imminent and massive lock-up expiration scheduled for March 13, 2026, when approximately 390 million shares of Class A common stock become eligible for public sale.
PATH shares fell approximately 10% in premarket trading on March 12, 2026, reversing the prior session's 6.82% gain, as investors digested Q4 fiscal 2026 earnings released after the close on March 11. The primary catalyst for the selloff was disappointing FY2027 revenue guidance, which implies approximately 8–9% top-line growth — a notable deceleration from the 13% growth delivered in FY2026.
TIC shares are down approximately 15% in premarket trading on March 12, 2026, ahead of the regular session open. Primary catalyst: TIC Solutions reported Q4 2025 earnings before market open, posting an adjusted loss of $0.25 per share — a miss of $0.33 against the analyst consensus of -$0.08 per share.
HIMX shares surged approximately +33% in premarket trading on March 12, 2026, with the stock climbing from a prior close of $9.15 to around $12.19–$12.56. The primary catalyst is a renewed wave of AI-driven semiconductor enthusiasm surrounding Himax's Co-Packaged Optics (CPO) technology and its potential role as a supplier to major players including NVIDIA and Taiwan Semiconductor Manufacturing.
GIII shares fell approximately 15.65% in early trading on March 12, 2026, after the company reported its fiscal Q4 and full-year 2026 earnings before the bell. Q4 net sales dropped 8.1% year-over-year to $771.5 million, missing Wall Street's consensus estimate of approximately $792 million.
LWLG shares surged approximately 42% in early trading on March 12, 2026, building on a 15% rally from the prior session, as the stock's multi-day momentum accelerated into the regular open. The primary catalyst is Lightwave Logic's newly announced silicon photonics development agreement with Tower Semiconductor (TSEM), integrating its electro-optic polymer modulator technology into Tower's PH18 platform.
IperionX (NASDAQ: IPX) shares fell approximately 15% in Thursday's session, with the ADR trading around $42.70 after closing at $50.26 the prior session. The primary catalyst was the company's half-year financial report (H1 FY2026, ending December 31, 2025), which revealed a sharply wider net loss of US$34.8 million — more than double the US$16.2 million loss reported in the prior corresponding period.
SITM shares are down approximately 10% in Thursday's trading session, extending a multi-week decline from February highs near $447. The primary catalyst is a broad-based semiconductor sector selloff driven by intensifying tariff fears and macro uncertainty under the Trump administration's escalating trade policy.
RHLD shares dropped over 24% today, accelerating a recent downtrend that had already left the stock roughly 15–17% lower over the past month before today’s earnings‑driven selloff. For 2025, Resolute reported sales of about $462 million, up modestly from the prior year, but its net loss widened to roughly $5.9 million versus a $2.3 million loss in 2024.
VEON shares fell more than 14% today, a sharp reversal that follows a 12‑month gain of roughly 120% and year‑to‑date return near 45%, leaving the stock vulnerable to profit‑taking.​ The move comes just one day before VEON is scheduled to release its Q4 and full‑year 2025 results, prompting pre‑earnings de‑risking from traders who had enjoyed substantial gains.​
Applied Optoelectronics (AAOI) Stock Falls Over -14% as Overheated Rally Meets Profit-Taking and Valuation Jitters
AERO fell over 14% today, trading as low as about $14.15 and recently changing hands near $14.41, down from a prior close around $16.80 and marking a new 12‑month low. The drop follows a brief rally earlier this week, but the stock remains down more than 20% over the past year despite Grupo Aeromexico posting record 2025 margins and robust profitability. Investors appear concerned that management’s bullish 2026 guidance — calling for mid‑ to high‑single‑digit revenue growth and high‑20% EBITDA margins — may prove challenging amid cost inflation and competitive pressures.
EVCM shares are plunging approximately 23% in premarket trading on March 13, 2026, following the company's Q4 2025 earnings release after the prior session's close. The primary catalyst is a significant EPS miss — EverCommerce reported adjusted EPS of $0.03, badly missing the consensus estimate of $0.05, a 40% negative earnings surprise.
ADBE shares are down approximately 8.67% in premarket trading on March 13, 2026, erasing gains from the prior session. The primary catalyst is the surprise announcement that longtime CEO Shantanu Narayen will step down after 18 years once a successor is named.
ULTA shares are declining sharply in premarket trading on March 13, 2026, extending losses that began after the company's earnings release after the close on March 12 — with the stock down approximately 8.3% in premarket, building on a -4.28% decline during the regular session on March 12. The primary catalyst is fiscal 2026 earnings guidance that fell short of Wall Street expectations, with the company projecting diluted EPS of $28.05–$28.55 against analyst consensus of approximately $28.58.
EONR is trading approximately +10% higher in Friday's premarket session, extending a powerful multi-day rally that has seen the stock surge over 250% year-to-date. The primary catalyst is the company's newly expanded oil hedging program, locking in favorable pricing through 2027 as oil prices spike amid geopolitical tensions in the Middle East.